Bordeaux
Ask VT AI
View News Summary
- Novartis nears $70 billion acquisition of Avidity Biosciences to expand its RNA therapeutics pipeline for neuromuscular diseases.
- Russia tests nuclear-powered cruise missile, experts raise concerns over technical challenges and proliferation risks.
- Heavyweight title fight ends in no-contest, rematch planned after Aspinall's eye injury
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Novartis nears $70 billion acquisition of Avidity Biosciences to expand its RNA therapeutics pipeline for neuromuscular diseases.
- Russia tests nuclear-powered cruise missile, experts raise concerns over technical challenges and proliferation risks.
- Heavyweight title fight ends in no-contest, rematch planned after Aspinall's eye injury
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Bordeaux
News from Bordeaux
